Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2018

  1. TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence

    Journal of Clinical Investigation, Vol. 128, Núm. 9, pp. 3887-3905